- Home
- IMVT vs HTGC Comparison
IMVT vs HTGC Comparison
Compare IMVT & HTGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMVT
- HTGC
- Stock Information
- Founded
- IMVT N/A
- HTGC 2003
- Country
- IMVT United States
- HTGC United States
- Employees
- IMVT N/A
- HTGC N/A
- Industry
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- HTGC Investment Managers
- Sector
- IMVT Health Care
- HTGC Finance
- Exchange
- IMVT Nasdaq
- HTGC Nasdaq
- Market Cap
- IMVT 3.6B
- HTGC 3.3B
- IPO Year
- IMVT N/A
- HTGC 2005
- Fundamental
- Price
- IMVT $23.86
- HTGC $20.74
- Analyst Decision
- IMVT Strong Buy
- HTGC Buy
- Analyst Count
- IMVT 11
- HTGC 9
- Target Price
- IMVT $46.11
- HTGC $20.50
- AVG Volume (30 Days)
- IMVT 1.1M
- HTGC 977.3K
- Earning Date
- IMVT 02-10-2025
- HTGC 02-13-2025
- Dividend Yield
- IMVT N/A
- HTGC 7.71%
- EPS Growth
- IMVT N/A
- HTGC 1.34
- EPS
- IMVT N/A
- HTGC 2.01
- Revenue
- IMVT N/A
- HTGC $494,410,000.00
- Revenue This Year
- IMVT N/A
- HTGC $10.55
- Revenue Next Year
- IMVT N/A
- HTGC $5.06
- P/E Ratio
- IMVT N/A
- HTGC $10.32
- Revenue Growth
- IMVT N/A
- HTGC 12.81
- 52 Week Low
- IMVT $22.41
- HTGC $16.72
- 52 Week High
- IMVT $41.38
- HTGC $21.78
- Technical
- Relative Strength Index (RSI)
- IMVT 40.92
- HTGC 67.77
- Support Level
- IMVT $22.41
- HTGC $19.48
- Resistance Level
- IMVT $25.29
- HTGC $20.65
- Average True Range (ATR)
- IMVT 1.25
- HTGC 0.35
- MACD
- IMVT 0.03
- HTGC 0.06
- Stochastic Oscillator
- IMVT 42.90
- HTGC 88.38
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).
About HTGC Hercules Capital Inc.
Hercules Capital Inc is a specialty finance company engaged in providing senior secured loans to high-growth, venture capital-backed companies in a variety of technology, life sciences, and sustainable and renewable technology industries. It invests majorly in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The company lends to and invests in portfolio companies in various technology-related industries including technology, drug discovery and development, biotechnology, life sciences, healthcare, and sustainable and renewable technology.